Abivax S.A.
Pharmaceutical company · Paris, Île-de-France, France · Nasdaq: ABVX
Abivax S.A. is a pharmaceutical company headquartered in Paris, Île-de-France, France. Its shares trade on Nasdaq under the ticker ABVX.
Profile compiled from public records. Is this your company? Request a correction or update
Abivax at a glance
Typepharmaceutical company
HeadquartersParis, Île-de-France, France
Stock listingNasdaq: ABVX
SEC industryPharmaceutical Preparations
SEC CIK1956827
Frequently asked questions about Abivax
Where is Abivax headquartered?
Abivax S.A. is headquartered in Paris, Île-de-France, France.
What does Abivax do?
Abivax S.A. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Abivax a public company?
Yes. Abivax S.A. trades on Nasdaq under the ticker ABVX.
Similar companies
- SanofiParis, Île-de-France, France
- Biophytis SAParis, Île-de-France, France
- Nanobiotix S.A.Paris, Île-de-France, France
- Maco PharmaMouvaux, Hauts-de-France, France
- Crossject SADijon, Bourgogne-Franche-Comté, France
- Guerbet LLCLanester, Brittany, France
- Advanced Accelerator Applications S.A.Saint-Genis-Pouilly, Auvergne-Rhône-Alpes, France
- Dynacure S.A.Illkirch-Graffenstaden, Grand Est, France
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences